Chemed earnings were $275.0M for the trailing 12 months ending Jun 30, 2026, with 1.5% growth year over year. The latest CHE earnings report on Jun 30, 2026 announced Q2 2026 earnings of $67.7M, up 2.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CHE reported annual earnings of $265.2M, with -12.2% growth.
CHE past earnings growth
How has CHE's earnings growth performed historically?
On CHE's earnings call on Jul 28, 2026, Chemed (NYSE: CHE) reported Q2 2026 earnings per share (EPS) of $5.14, up 42.78% year over year. Total CHE earnings for the quarter were $67.70 million. In the same quarter last year, Chemed's earnings per share (EPS) was $3.60.
As of the last Chemed earnings report, Chemed is currently profitable. Chemed's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $274.99 million, a 5.29% decrease year over year.
What was CHE's earnings growth in the past year?
As of Chemed's earnings date in Jul 28, 2026, Chemed's earnings has grown 1.48% year over year. This is 66.04 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 67.51%. CHE earnings in the past year totalled $274.99 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.